Display options
Share it on

Front Oncol. 2015 Feb 11;5:29. doi: 10.3389/fonc.2015.00029. eCollection 2015.

Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature.

Frontiers in oncology

Naveen Pemmaraju, Koji Sasaki, Daniel Johnson, Naval Daver, Vahid Afshar-Kharghan, Merry Chen, Sairah Ahmed, Rivka R Colen, Michael Kwon, Yang Huh, Gautam Borthakur

Affiliations

  1. Department of Leukemia, MD Anderson Cancer Center , Houston, TX , USA.
  2. Department of Internal Medicine, Louisiana State University , New Orleans, LA , USA.
  3. Department of Benign Hematology, MD Anderson Cancer Center , Houston, TX , USA.
  4. Department of Neuro-Oncology, MD Anderson Cancer Center , Houston, TX , USA.
  5. Department of Stem Cell Transplantation, MD Anderson Cancer Center , Houston, TX , USA.
  6. Department of Diagnostic Radiology, MD Anderson Cancer Center , Houston, TX , USA.
  7. Department of Hematopathology, MD Anderson Cancer Center , Houston, TX , USA.

PMID: 25717439 PMCID: PMC4324079 DOI: 10.3389/fonc.2015.00029

Abstract

Intracranial hemorrhage (ICH) is a common complication in acute myeloid leukemia (AML) patients with an incidence rate of 6.3% (1). Bleeding disorders related to disseminated intravascular coagulation (DIC) are common complications in AML cases (2). Recombinant activated Factor VII [rFVIIa (NovoSeven(®))] is approved for the treatment of bleeding complications with FVIII or FIX inhibitors in patients with congenital FVII deficiency. Use of rFVIIa for the treatment of acute hemorrhage in patients without hemophilia has been successful (3, 4). Herein, we describe the successful use of rFVIIa in a patient with acute ICH in the setting of newly diagnosed AML.

Keywords: acute myeloid leukemia; intracranial hemorrhage; recombinant activated factor VII

References

  1. Stroke. 2010 Sep;41(9):2108-29 - PubMed
  2. Bone Marrow Transplant. 2007 Jun;39(12 ):729-35 - PubMed
  3. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD005011 - PubMed
  4. BMC Med. 2012 Aug 29;10:97 - PubMed
  5. Leuk Lymphoma. 2012 Jan;53(1):160-1 - PubMed
  6. Cancer. 1987 Dec 15;60(12):3071-9 - PubMed
  7. Crit Care. 2006;10(6):R178 - PubMed
  8. Blood Coagul Fibrinolysis. 2007 Oct;18(7):589-93 - PubMed
  9. Neurocrit Care. 2005;2(3):263-7 - PubMed
  10. N Engl J Med. 2011 Feb 10;364(6):575; author reply 575-6 - PubMed
  11. N Engl J Med. 2008 May 15;358(20):2127-37 - PubMed
  12. Int J Hematol. 2007 Aug;86(2):137-42 - PubMed
  13. Cochrane Database Syst Rev. 2013 Aug 30;(8):CD001245 - PubMed
  14. Blood Coagul Fibrinolysis. 2004 Oct;15(7):577-82 - PubMed
  15. N Engl J Med. 2005 Feb 24;352(8):777-85 - PubMed

Publication Types